All posts
16742 total · page 2 of 335
GE HealthCare Eyes $1 Billion Acquisition of Sofie Biosciences
GE HealthCare is reportedly negotiating a $1 billion purchase of Sofie Biosciences, enhancing its cancer scan capabilities.
Ultrasound AI Achieves Major Milestone with Two New Patents
Cutting-edge ultrasound AI technology secures two new patents, advancing medical imaging capabilities.
AI Revolutionizes Medical Imaging with FDA Approvals and Smarter Scans
AI is reshaping radiology with FDA-approved tools and advanced imaging techniques, signaling a new era in medical diagnostics.
CDSCO Establishes Panel to Oversee AI in Drug Discovery
India's CDSCO forms an expert panel to regulate AI in drug discovery, enhancing safety.
Anthropic Establishes Secretive Biology Lab for AI-Driven Drug Research
Anthropic has discreetly launched a biology lab to enhance its AI-based drug discovery efforts.
AI Agents Revolutionize Drug Discovery at Virtual Biotech Firm
A biotech firm pioneers drug discovery by deploying AI agents in collaboration with Stanford Medicine.
FDA Approves AI Software for Enhanced Chest X-Ray Analysis
The FDA has approved an AI tool designed to improve chest X-ray analysis, marking a significant advancement in radiology.
AI Technique Enhances Safety and Precision in Minimally Invasive Surgeries
A new AI-driven approach promises to improve the accuracy and safety of minimally invasive surgeries, potentially transforming patient outcomes.
Hospitals Urged to Develop Radiology AI Strategy Prior to Investment
Experts stress the need for a strategic management plan before hospitals invest in radiology AI, highlighting potential challenges and benefits.
Molbio Diagnostics Reports Rs 52.7 Crore Profit in Q1 Post-IPO
Molbio Diagnostics has recorded a Rs 52.7 crore profit in Q1, a significant turnaround from last year's loss.
Indian AI Platform for Cancer Care Gains Spotlight at BRICS Summit
iOncology.ai, a pioneering AI platform for cancer care from India, is featured in the BRICS Health Journal, highlighting its potential to transform cancer treatment.
Waystar Weighs Sale Amid Software Sector Challenges
Waystar is considering a sale two years after its public listing, as its stock value declines.
GE HealthCare Eyes $1 Billion Acquisition of Sofie Biosciences
GE HealthCare is negotiating a $1 billion purchase of Sofie Biosciences, enhancing its diagnostic capabilities.
Rapid Diagnostic Tests: A Lifeline in Humanitarian Crises
Rapid diagnostic tests are transforming infectious disease surveillance in crises, offering swift, reliable results.
New Malaria Test in Ethiopia: A Game-Changer for Diagnosis
A multi-antigen malaria test shows promise against qPCR and microscopy in Ethiopia.
MGI Debuts VisiOmics and AI Pathology Tools at ECP 2026 in Europe
MGI introduces VisiOmics in Europe and unveils AI pathology innovations at ECP 2026, promising advancements in diagnostic precision.
AI Transforms Dermatology: Adoption Rate Raises Integration Concerns
AI's rapid integration into dermatology offers promise but demands cautious implementation to ensure patient safety and efficacy.
AI's Expanding Role in Eye Care Discussed at ESCRS 2026 by Dr. Jai Parekh
Dr. Jai Parekh highlights AI's transformative impact on ophthalmology at ESCRS 2026.
Invisible AI: How Ambient Intelligence Is Transforming Tech
Ambient Intelligence is making AI seamlessly integrate into daily life, altering how we interact with technology.
NIT Raipur Hosts International Conference on Health Tech Innovations
NIT Raipur's 4th International Conference focuses on ambient intelligence in healthcare.
Oracle's AI Tool Eases Nurses' Documentation, Enhances Patient Care
Oracle unveils a Clinical AI Agent that reduces nurses' documentation workload, improving patient care efficiency.
AI Transforms Medical Documentation Amidst Emerging Risks
AI reshapes medical documentation and coding, offering efficiency but posing legal risks.
Molbio Diagnostics Reports Rs 52.74 Cr Profit in Q1 After IPO
Molbio Diagnostics posts Rs 52.74 crore profit in Q1 FY27, reversing last year's loss, boosted by Truenat test-kit sales.
Indian AI Cancer Platform iOncology.ai Gains BRICS Health Journal Spotlight
iOncology.ai, an Indian AI platform for cancer care, is featured in the BRICS Health Journal, highlighting its potential to transform cancer treatment.
Waystar Weighs Sale Amidst Decline in Market Value, Sources Reveal
Healthcare software firm Waystar is considering a sale after a share price drop, sources say.
Y Chromosome Loss in Men: Potential Early Cancer Indicator
Research suggests that the loss of the Y chromosome in men could signal an increased cancer risk.
GE HealthCare Eyes $1 Billion Acquisition of Sofie Biosciences
GE HealthCare is reportedly negotiating a $1 billion purchase of Sofie Biosciences, a leader in cancer scan chemicals.
Molbio Diagnostics Reports Rs 52.7 Cr Profit in Q1 Post-IPO
Molbio Diagnostics turned a profit of Rs 52.74 crore in Q1, reversing a loss from the previous year, buoyed by strong Truenat test-kit sales.
Indian AI Platform iOncology.ai Gains Spotlight in BRICS Health Journal
iOncology.ai, an AI cancer care platform, is featured in the BRICS Health Journal, highlighting India's innovation in healthcare technology.
Waystar Considers Sale as Market Value Slumps Amid Software Sector Decline
Waystar explores strategic options, including a potential sale, after a significant drop in market value.
GE HealthCare Eyes $1 Billion Acquisition of Sofie Biosciences
GE HealthCare is reportedly negotiating a $1 billion acquisition of Sofie Biosciences to enhance its diagnostics division.
Biotechnology and AI: Navigating New Opportunities and Responsibilities
The convergence of biotechnology and AI presents unprecedented opportunities and ethical challenges.
New Frontier in Protein Secretion: Synthetic Switches in Cells
Researchers explore unconventional protein secretion as a design tool for synthetic biology, expanding beyond traditional ER-Golgi pathways.
New IGZO Biosensor Platform Enhances Stability, Detects Cortisol
A breakthrough IGZO biosensor offers improved mechanical stability and precise cortisol detection, advancing flexible electronics.
Innovative Biosensor Transforms Molecular Signals into Visual Data
A new biosensor converts molecular signals into images, eliminating the need for traditional spectrometers.
Point-of-Care Diagnostics Market Poised for Growth by 2035
The point-of-care diagnostics market is set for significant expansion by 2035, driven by technological advancements and increased demand.
Rising Demand for Carbon Monoxide Sensors in Healthcare by 2035
The carbon monoxide sensor market is expanding, driven by healthcare needs in patient monitoring and surgical safety.
Molbio Diagnostics Reports Rs 52.7 Crore Profit in Q1 After IPO
Molbio Diagnostics achieved a Rs 52.7 crore profit in Q1, rebounding from a loss last year, driven by strong Truenat test-kit sales.
Indian AI Platform iOncology.ai Gains Spotlight in BRICS Health Journal
iOncology.ai, developed by AIIMS and C-DAC, is featured in the BRICS Health Journal, showcasing its potential to transform cancer care in emerging economies.
Waystar Considers Sale Amid Declining Market Value
Waystar is exploring strategic options, including a potential sale, following a significant drop in its market value.
Ebola Outbreak Updates: Progress and Challenges from May to September
The Ebola outbreak in Eastern Congo shows signs of control but remains serious, with particular impact on women and girls.
GE HealthCare Eyes $1 Billion Acquisition of Sofie Biosciences
GE HealthCare is negotiating a $1 billion acquisition of Sofie Biosciences, a leader in cancer scan chemicals.
Molbio Diagnostics Reports Rs 52.7 Crore Profit in Q1 Post-IPO
Molbio Diagnostics announced a Rs 52.7 crore profit for Q1, reversing last year's loss, following its recent IPO.
iOncology.ai: India's AI Platform for Cancer Care Gains BRICS Spotlight
iOncology.ai, developed by AIIMS and C-DAC, is featured in BRICS Health Journal for its role in transforming cancer care.
Waystar Weighs Sale Amid Falling Valuations in Software Sector
Waystar, a healthcare software firm, is exploring a sale with Evercore's guidance, sources reveal.
GE HealthCare Eyes $1 Billion Acquisition of Sofie Biosciences
GE HealthCare is negotiating a $1 billion deal to acquire Sofie Biosciences, enhancing its diagnostics division.
Molbio Diagnostics Reports Rs 52.7 Cr Profit in Q1 After IPO Success
Molbio Diagnostics posted a Rs 52.7 crore profit in Q1, rebounding from a loss last year, buoyed by strong Truenat test-kit sales.
Indian AI Platform iOncology.ai Showcased in BRICS Health Journal
iOncology.ai, developed by AIIMS and C-DAC, aims to enhance cancer care in emerging economies and is highlighted at the BRICS Summit.
Waystar Considers Sale Amid Declining Valuation, Sources Reveal
Healthcare software firm Waystar may be up for sale, with Evercore advising. Its market value has dropped following a 24% share price fall.
GE HealthCare Eyes $1 Billion Acquisition of Sofie Biosciences
GE HealthCare is reportedly in talks to acquire radiopharmaceutical firm Sofie Biosciences for $1 billion, enhancing its cancer diagnostics capabilities.